Abstract 10201: Efficacy of Mavacamten in Patients with Symptomatic Hypertrophic Cardiomyopathy: Sub-Group Analyses by Background Beta-Blocker Use from the EXPLORER-HCM and MAVA-LTE Studies

Introduction: Mavacamten, a selective inhibitor of cardiac myosin, improved symptoms and exercise capacity (pVO2) in adults with obstructive hypertrophic cardiomyopathy (oHCM) (EXPLORER-HCM; NCT034...